Research institute
The new research showed that by blocking enzymes in the PIP2 recycling series, the series that turns PIP2 into inositol triphosphate and diacylglycerol and back to PIP2, they can stop angiogenesis (growth of new blood vessels).
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 19, 2020.
“By comparing the available genome sequence data for known coronavirus strains, we can firmly determine that SARS-CoV-2 originated through natural processes,” said Kristian Andersen, associate professor of immunology and microbiology at Scripps Research.
New insights into the architecture of the brain have been revealed by scientists at the Wellcome Sanger Institute, the Wellcome-MRC Cambridge Stem Cell Institute and their collaborators.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2020. We want to know how the coronavirus outbreak may be impacting your work and your workplace.
As the number of diagnosed cases of COVID-19 continue to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine and therapies for the respiratory infection that was declared a pandemic by the World Health Organization last week. Here’s a biopharma industry overview as of late March 16.
“We are extremely motivated to be working hand-in-hand with these premier institutes, among the leaders in cell-based immunotherapy discovery and development, to exhibit the use of the closed, automated Cocoon® Platform for manufacturing cell therapies.
New microfluidic process enables researchers to create unique environment for developing medicine that cannot be achieved through conventional methods, paving the way for more potent, high-quality drugs
PRESS RELEASES